Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Weaver

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
JAMA|September 8, 1993
Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention TrialW D Weaver, M Cerqueira, A P Hallstrom, et al.
Journal of the American College of Cardiology|July 21, 1998
Utility of the prehospital electrocardiogram in diagnosing acute coronary syndromes: the Myocardial Infarction Triage and Intervention (MITI) ProjectP J Kudenchuk, C Maynard, L A Cobb, et al.
The New England Journal of Medicine|September 15, 1988
Use of the automatic external defibrillator in the management of out-of-hospital cardiac arrestW D Weaver, D Hill, C E Fahrenbruch, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 1, 1995
Clinical studies with the new glycosylated recombinant prourokinaseA A Sasahara, W M Barker, W D Weaver, et al.
The New England Journal of Medicine|June 12, 1997
Absence of association between insurance copayments and delays in seeking emergency care among patients with myocardial infarctionD J Magid, T D Koepsell, N R Every, et al.
Journal of Women'S Health|June 1, 1997
Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesE K Moen, C R Asher, D P Miller, et al.
American Heart Journal|January 10, 1998
Use and accuracy of state death certificates for classification of sudden cardiac deaths in high-risk populationsN R Every, L Parsons, M A Hlatky, et al.
The Canadian Journal of Cardiology|April 28, 2006
N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarctionJustin A Ezekowitz, Pierre Théroux, Weiching Chang, et al.
Circulation|September 26, 2001
Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin IJ McCord, R M Nowak, P A McCullough, et al.
Journal of the American College of Cardiology|August 1, 1995
Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) TrialS W Zarich, G J Kowalchuk, W D Weaver, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
JAMA|September 8, 1993
Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention TrialW D Weaver, M Cerqueira, A P Hallstrom, et al.
Journal of the American College of Cardiology|July 21, 1998
Utility of the prehospital electrocardiogram in diagnosing acute coronary syndromes: the Myocardial Infarction Triage and Intervention (MITI) ProjectP J Kudenchuk, C Maynard, L A Cobb, et al.
The New England Journal of Medicine|September 15, 1988
Use of the automatic external defibrillator in the management of out-of-hospital cardiac arrestW D Weaver, D Hill, C E Fahrenbruch, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 1, 1995
Clinical studies with the new glycosylated recombinant prourokinaseA A Sasahara, W M Barker, W D Weaver, et al.
The New England Journal of Medicine|June 12, 1997
Absence of association between insurance copayments and delays in seeking emergency care among patients with myocardial infarctionD J Magid, T D Koepsell, N R Every, et al.
Journal of Women'S Health|June 1, 1997
Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesE K Moen, C R Asher, D P Miller, et al.
American Heart Journal|January 10, 1998
Use and accuracy of state death certificates for classification of sudden cardiac deaths in high-risk populationsN R Every, L Parsons, M A Hlatky, et al.
The Canadian Journal of Cardiology|April 28, 2006
N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarctionJustin A Ezekowitz, Pierre Théroux, Weiching Chang, et al.
Circulation|September 26, 2001
Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin IJ McCord, R M Nowak, P A McCullough, et al.
Journal of the American College of Cardiology|August 1, 1995
Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) TrialS W Zarich, G J Kowalchuk, W D Weaver, et al.
Pageof 17